featured
Efficacy of OnabotulinumtoxinA in Improving Oral Aperture in Patients With Scleroderma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial
J Am Acad Dermatol 2023 Jun 08;[EPub Ahead of Print], CD Gonzalez, JJ Pamatmat, KM Burningham, M Yang, HW GoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.